eth 615 has been researched along with wy 48252 in 1 studies
| Studies (eth 615) | Trials (eth 615) | Recent Studies (post-2010) (eth 615) | Studies (wy 48252) | Trials (wy 48252) | Recent Studies (post-2010) (wy 48252) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 15 | 0 | 0 |
| Protein | Taxonomy | eth 615 (IC50) | wy 48252 (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 3.3 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 6.2 | |
| Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 2 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Musser, JH | 1 |
1 review(s) available for eth 615 and wy 48252
| Article | Year |
|---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |